TARS filings
Corporate insider profile
Bobak R. Azamian Filing Activity
Latest reported as President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (TARS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,321,688.00
- Latest transaction
- Sep 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
